Sagimet Biosciences Inc. (SGMT)
USD 5.25
(-11.62%)
USD 5.25
(-11.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2 Million | - | - | - | - |
| Cost of Revenue | - | 130 Thousand | 134 Thousand | 124 Thousand | 88 Thousand |
| Gross Profit | 2 Million | -130 Thousand | -134 Thousand | -124 Thousand | -88 Thousand |
| Operating Expenses | 32.74 Million | 31.05 Million | 23.71 Million | 11.4 Million | 14.25 Million |
| Selling, General and Administrative Expenses | 12.96 Million | 6.13 Million | 4.37 Million | 3.21 Million | 5.86 Million |
| Research and Development Expenses | 19.77 Million | 24.91 Million | 19.34 Million | 8.18 Million | 8.39 Million |
| Other Expenses | - | 3000.00 | -749 Thousand | - | -73 Thousand |
| Cost and Expenses | 32.74 Million | 31.05 Million | 23.71 Million | 11.4 Million | 14.25 Million |
| Operating Income | -30.74 Million | -31.05 Million | -23.71 Million | -11.4 Million | -14.25 Million |
| Interest Expense | - | - | - | - | 64 Thousand |
| Income Tax Expense | - | -31.6 Million | -23.74 Million | -176.29 Thousand | -9000.00 |
| Earnings before Tax | -27.87 Million | -30.49 Million | -24.44 Million | -11.37 Million | -14.26 Million |
| Net Income | -27.87 Million | -30.49 Million | -24.44 Million | -11.37 Million | -14.26 Million |
| Earnings Per Share Basic | -2.66 | -1.38 | -1.10 | -0.51 | -0.64 |
| Earnings Per Share Diluted | -2.66 | -1.38 | -1.10 | -0.51 | -0.64 |
| Weighted Average Shares Outstanding | 10.46 Million | 22.17 Million | 22.17 Million | 22.17 Million | 22.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.46 Million | 22.17 Million | 22.17 Million | 22.17 Million | 22.17 Million |
| Gross Margin | 1.00 | - | - | - | - |
| EBIT Margin | -15.37 | - | - | - | - |
| Profit Margin | -13.94 | - | - | - | - |
| EBITDA | -30.74 Million | -30.36 Million | -24.3 Million | -11.24 Million | -14.1 Million |
| Earnings Before Tax Margin | -15.37 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 2 Million | - | 2 Million | - |
| Cost of Revenue | - | - | - | - | 35 Thousand | 34 Thousand |
| Gross Profit | - | - | 2 Million | - | 1.96 Million | -34 Thousand |
| Operating Expenses | 10.58 Million | 8.76 Million | 32.74 Million | 9.46 Million | 9.45 Million | 7.05 Million |
| Selling, General and Administrative Expenses | 4.27 Million | 3.5 Million | - | 3.81 Million | 4.49 Million | 2.38 Million |
| Research and Development Expenses | 6.31 Million | 5.26 Million | - | 5.65 Million | 4.95 Million | 4.67 Million |
| Other Expenses | - | - | - | 2000.00 | - | - |
| Cost and Expenses | 10.58 Million | 8.76 Million | 32.74 Million | 9.46 Million | 9.45 Million | 7.05 Million |
| Operating Income | -10.58 Million | -8.76 Million | -30.74 Million | -9.46 Million | -7.45 Million | -7.05 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -10.58 Million | -8.76 Million | -2.86 Million | -1.31 Million | -1.09 Million | -271 Thousand |
| Earnings before Tax | -8.11 Million | -6.62 Million | -27.87 Million | -8.15 Million | -6.35 Million | -6.78 Million |
| Net Income | -8.11 Million | -6.62 Million | -27.87 Million | -8.15 Million | -6.35 Million | -6.78 Million |
| Earnings Per Share Basic | -0.25 | -0.23 | - | -0.45 | -0.35 | -0.31 |
| Earnings Per Share Diluted | -0.25 | -0.23 | - | -0.45 | -0.35 | -0.31 |
| Weighted Average Shares Outstanding | 31.91 Million | 29.03 Million | 23.61 Million | 18.19 Million | 18.19 Million | 22.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.91 Million | 29.03 Million | 23.61 Million | 18.19 Million | 18.19 Million | 22.17 Million |
| Gross Margin | - | - | 1.00 | - | 0.98 | - |
| EBIT Margin | - | - | - | - | -3.73 | - |
| Profit Margin | - | - | -13.94 | - | -3.18 | - |
| EBITDA | -10.58 Million | -8.76 Million | - | -9.46 Million | -7.45 Million | -7.05 Million |
| Earnings Before Tax Margin | - | - | -15.37 | - | -3.73 | - |
ALEGF
SXYAY
AQST
300548
CSLM
688690